The Expression of MiR-26a-5p in Plasma of Patients with Acute Heart Failure and Its Relationship with Short-Term Prognosis

CUI Fusheng

PDF(1172 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1172 KB)
Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (4) : 608-612. DOI: 10.11748/bjmy.issn.1006-1703.2022.04.015
Clinical Investigation

The Expression of MiR-26a-5p in Plasma of Patients with Acute Heart Failure and Its Relationship with Short-Term Prognosis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(4): 608-612 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.04.015

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1172 KB)

Accesses

Citation

Detail

Sections
Recommended

/